#DontDiscountMenB

Despite the UK government seeming to dismiss wider use of MenB vaccine on the grounds of cost-effectiveness, at MRF we believe that the battle is far from over

We are campaigning for protection for all against MenB and fair access to vaccines by:

  • Securing a commitment to funding and delivering the adolescent carriage/intervention study we believe teenagers are key to getting rid of MenB bacteria and protecting the whole UK population
  • Addressing the unfairness of the current cost effectiveness framework - we think the current unfairness means that MenB and future vaccines against other types of meningitis will always face and uphill struggle to be adopted.
  • Protecting the most vulnerable with an effective vaccine and undertake a catch-up for under-5s
Along with Meningitis Now, we've come up with a ten-point action plan to make these things happen.

We are asking the UK government

#DontDiscountMeningitis




MenB Vaccine Research Appeal

Help fund ground breaking research to provide the evidence for wider use of MenB vaccination in the UK
.

Page last updated 05.04.16

MenB by numbers

  • 1761 average cases of MenB in UK per year
  • 10% of cases will result in death
  • 10% of survivors will have a major disability including amputations, brain damage and hearing loss
  • 33% of survivors will have minor deficits including psychological disorders & reduced IQ
  • 640,000 doses have been distributed worldwide
  • 73% in UK and 78% in Europe predicted coverage of new MenB vaccine
  • 22 years since the first meningitis vaccine introduced – Hib 1992